Boston Scientific Corporation (BSX) — closed signal from August 19, 2025
Partial Published before the outcome was known, scored automatically when the window closed on November 17, 2025.
Predicted vs. what happened
What happened
Reached 49% of the predicted growth at its peak, without hitting the target.
The thesis — published August 19, 2025
Boston Scientific makes reliable medical devices, and its share price looks tired after a pullback, which often sets up a short-term rebound. Investor mood is strong, even though trend signals are still soft. Fresh news in healthcare, like new blood tests, shows the industry is advancing. If more parts of the market start rising, the stock could drift back toward its usual range over the next 0-3 months.
Primary drivers
- Price looks washed out and investor mood is very positive, hinting at a bounce.
- Steady stock from a high-quality business, less likely to swing wildly.
- Healthcare is seeing new products, which can lift demand for its devices.
- We need signs that buying is spreading before expecting a stronger move.
How it played out
BSX: target was not reached
Lyra published BSX at $102.51 on 2025-08-19 with a short-term thesis for 14% expected growth. The thesis pointed to a tired share price after a pullback, positive investor mood, steady medical-device quality, healthcare product activity, and the need for broader buying before a stronger move.
Inside the window, BSX rose to $109.50 on 2025-09-09, a 6.8% peak gain. It stayed below the $116.86 target, so the target was never reached. By 2025-11-17, it ended at $101.76. The thesis partly played out, but the move stopped well short of the published target.
What happened during the window
On 2025-10-22, Investor's Business Daily reported that Boston Scientific posted adjusted earnings of $0.75 per share on $5.07 billion in revenue for the third quarter. The same report said Watchman sales grew 35% and electrophysiology sales grew 63%.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.